Bloomberg: With Magic Mushrooms, Small Businesses Lead, Hoping Laws Will Follow

Summary: “There is a lot of clandestine investment in currently underground or gray-market areas. Decriminalization provides a level of protection for behaviors that are already occurring,” says Ismail Ali, J.D., MAPS Director of Policy and Advocacy, in Bloomberg. “Psilocybin—the main hallucinogenic compound in more than 180 mushroom strains—has shown impressive results for conditions such as depression, anxiety, and drug and alcohol addiction that have long been resistant to established medical treatments,” writes Michelle Lhooq of Bloomberg.

Originally appearing here (Archived)